ALGN · Align Technology Inc
Price & Indicators
Up next
AI Brief
TL;DR.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders BuyIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Clear Aligner Shipments | 691,785 | Q2'26 | — |
|
|
|||
| Clear Aligner volume | 691.8K | Q2'26 | — |
|
|
|||
| non-GAAP diluted net income per share non-GAAP | $2.64 | Q2'26 | — |
|
|
|||
| non-GAAP gross margin non-GAAP | 72.3% | Q2'26 | — |
|
|
|||
| non-GAAP operating margin non-GAAP | 22.9% | Q2'26 | — |
|
|
|||
| Clear Aligner shipments to GP Dentists | 5.6% | Q1'26 | — |
| Clear Aligner shipments to Orthodontists | 7.4% | Q1'26 | — |
| Invisalign adult patients | 7.8% | Q1'26 | — |
| Invisalign teen/kid patients | 4.8% | Q1'26 | — |
| active Invisalign trained doctors | 295K | 2025 | — |
| active iTero scanner units | 121K | 2025 | — |
| Clear Aligner volumes up year-over-year for adult patients | 8% | Q4'25 | — |
| Clear Aligner volumes up year-over-year in teens and kids | 6.9% | Q4'25 | — |
| Clear Aligner volumes up year-over-year in the GP dentist channel | 5.3% | Q4'25 | — |
| Clear Aligner volumes up year-over-year in the Orthodontic channel | 8.9% | Q4'25 | — |
| clear aligners manufactured worldwide | 2.4B | 2025 | — |
| doctors submitted Invisalign cases globally | 87.7K | Q4'25 | — |
| exocad CAD/CAM licenses | 70K | 2025 | — |
| Invisalign DSP Touch Up cases shipped | 136K | 2025 | — |
| Invisalign patients | 22M | 2025 | — |
| iTero Lumina share of full systems units | 86% | Q4'25 | — |
| teens and kids started treatment with Invisalign clear aligners | 935.8K | 2025 | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Medical Instruments & Supplies — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
ALGN
this stock
Align Technology Inc
|
$12.52B | +12.0% | +23.9% | 29.4 | 6.7% |
|
ISRG
Intuitive Surgical Inc
|
$132.55B | -33.8% | +20.5% | 43.1 | 1.9% |
|
MDLN
Medline Inc.
|
$48.20B | -12.7% | +11.5% | — | 2.2% |
|
BDX
Becton Dickinson & Co
|
$47.02B | +13.4% | +8.2% | 64.9 | 3.8% |
|
ALC
Alcon Inc
|
$34.42B | -10.0% | +10.5% | — | 2.7% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| ALGN | -2.9% | +0.1% | -11.5% | +3.4% | +12.0% |
| SPY | +5.5% | +3.3% | +11.3% | +3.1% | +12.9% |
| vs SPY | -8.5% | -3.2% | -22.7% | +0.3% | -0.9% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.